$50.17 0.00 (0%)
2/10/2012 4:00 PM

Express Scripts, Inc. (NASDAQ:ESRX)

CAPS Rating: 4 out of 5

Provides pharmacy benefit management services, including retail drug card programs, mail pharmacy services, drug formulary management programs and other clinical management programs for HMOs, health insurers, third-party administrators and employers.

Results 1 - 20 of 80 : 1 2 3 4 Next »

Recs

0
Member Avatar hunter694 (27.41) Submitted: 2/9/2012 6:37:28 PM : Outperform Start Price: $49.81 ESRX Score: +0.57

I really hope the merger get's the approval of the FTC!

Recs

0
Member Avatar Distressedstar (92.09) Submitted: 2/8/2012 11:52:28 PM : Outperform Start Price: $50.88 ESRX Score: -0.62

0.6

Recs

0
Member Avatar EBStroke (< 20) Submitted: 2/6/2012 8:05:32 PM : Underperform Start Price: $50.52 ESRX Score: +0.84

negative news on merger with MedcoHealth Solutions (NYSE: MHS),

Recs

0
Member Avatar MHenage (< 20) Submitted: 2/1/2012 1:58:42 PM : Outperform Start Price: $52.08 ESRX Score: -4.81

Positive free cash flow of nearly $450 million average per quarter in the last year. nuff said.

Recs

0
Member Avatar Hawk46 (< 20) Submitted: 1/29/2012 10:06:19 PM : Outperform Start Price: $50.54 ESRX Score: -3.82

Generics increasing.

Recs

0
Member Avatar sikiliza (71.92) Submitted: 1/25/2012 3:18:09 PM : Outperform Start Price: $52.51 ESRX Score: -5.75

Baby boomers

Recs

1
Member Avatar hrmtcrb (88.38) Submitted: 10/22/2011 8:06:27 AM : Outperform Start Price: $39.35 ESRX Score: +19.29

The expected merger with MHS coupled with the growing baby boom population and wider availability of generic alternatives to brand name medications should make this a winner for the next few years.

Recs

0
Member Avatar 45mm (< 20) Submitted: 9/14/2011 3:17:54 PM : Outperform Start Price: $43.44 ESRX Score: +3.71

Below 200 day moving avg. should rebound once merger takes place

Recs

0
Member Avatar StockDocStan (< 20) Submitted: 9/9/2011 10:46:31 AM : Outperform Start Price: $45.06 ESRX Score: -2.57

With or without Medco, Express Scripts will be a long-term winner, and I don't see how that has been less than obvious lately for the market.

Recs

0
Member Avatar Jaxxs (37.54) Submitted: 7/21/2011 8:23:41 AM : Outperform Start Price: $56.65 ESRX Score: -12.16

Drugs are good

Recs

1
Member Avatar BoiseKen (94.94) Submitted: 7/21/2011 7:17:28 AM : Outperform Start Price: $56.65 ESRX Score: -12.16

They might get knocked down shortterm from the MHS deal, but longterm, I think they paid a great price for a longterm boost. Generic drugs going off patent along with MHS' individualized medicine and depth of skill make this a winner.

Recs

0
Member Avatar jimndena (86.60) Submitted: 7/1/2011 1:20:15 PM : Outperform Start Price: $54.12 ESRX Score: -7.89

JC Pick

Recs

0
Member Avatar troym72 (37.90) Submitted: 6/7/2011 2:05:04 PM : Outperform Start Price: $57.01 ESRX Score: -15.39

Express Scripts is in a great position to take advantage of the aging population which will is in greater and greater need for regular maintenance medications, which falls right into their mail-order strategy. Increasing Revenue and EPS over the last 5 years shows that Express Scripts has the leadership and direction to keep growing for years to come.

Recs

0
Member Avatar Humle100 (95.68) Submitted: 5/29/2011 2:34:06 AM : Outperform Start Price: $58.95 ESRX Score: -14.59

Long term hold - predictability

Recs

0
Member Avatar stovkey1highdiv (< 20) Submitted: 5/10/2011 1:29:33 AM : Outperform Start Price: $59.21 ESRX Score: -14.67

key03, no div

Recs

0
Member Avatar Vanheezy18 (82.08) Submitted: 4/24/2011 9:22:14 PM : Outperform Start Price: $56.04 ESRX Score: -10.98

ESRX will beat earnings tomorrow causing stock price to appreciate

Recs

0
Member Avatar csmoult (< 20) Submitted: 1/5/2011 11:34:03 AM : Outperform Start Price: $56.31 ESRX Score: -16.34

Between 1993 and 1999 I invested a total of 28,700. In Express Scripts. From 1999 to the present I just sat on this stock. I now have 24,000 shares worth over 1.3 million.
In my opinion this is the ultimate buy-and-hold growth stock. Every time the price rises to $100 they split the stock making it more attractive to small investors. They have consistently grown the company by acquiring smaller competitors and seamlessly integrating them into the company's operation. Recently they have stood up to labor unions by shifting work away from areas where labor is hostile to them to areas where labor is willing to work with them.

Recs

0
Member Avatar daddybyday (33.38) Submitted: 11/10/2010 4:18:30 PM : Outperform Start Price: $52.15 ESRX Score: -14.79

And yet another SMA crossover experiment.

Recs

2
Member Avatar fightingamish2 (< 20) Submitted: 7/1/2010 3:42:21 PM : Outperform Start Price: $45.95 ESRX Score: -21.42

great price, well positioned in its market, low PEGY ratio

Recs

1
Member Avatar CellBlock9 (96.16) Submitted: 6/30/2010 9:34:03 PM : Outperform Start Price: $46.93 ESRX Score: -23.35

S&P 5 stars

Results 1 - 20 of 80 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement